… secondary objectives to assess virus and symptom kinetics during infection. Our findings
demonstrate the feasibility of deliberate infection with SARS-CoV-2, with no evidence of major …

The within-host viral kinetics of SARS-CoV-2 infection and how they relate to a person’s
infectiousness are not well understood. This limits our ability to quantify the impact of …

… viral load kinetics are shown. This report suggests that viral load kinetics of SARS-CoV-2 …
be different from that of previously reported other coronavirus infections such as SARS-CoV. …

… At the end of 2019, a novel coronavirus emerged, later termed severe acute …
coronavirus 2 (SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19). …

… We investigated IgM and IgG responses against SARS-CoV-2 nucleocapsid (N) and spike
(S… This study investigated the kinetics of N and S specific IgM and IgG responses in COVID-19 …

… kinetics … SARS-CoV-2 antibody kinetics have found that IgA and IgM peak between week
3 and 4 post symptoms onset (PSO) and wane thereafter, with IgA persisting longer than IgM 2,3…

… of a typical SARS-CoV-2 patient peaks just … SARS-CoV-2 control is restricted to scenarios
where interventions are synergistically combined, owing to the particular transmission kinetics …

… acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral kinetics in hospitalized …
viral kinetics in 655 hospitalized patients from the prospective French COVID cohort. The model …

… in COVID-19 cases. Here, we report the viral kinetics according to the absence or presence
of symptoms. This study included patients with laboratory-confirmed COVID-19 admitted to …

… to the spike (S) surface glycoprotein, and SARS-CoV-2–specific T cells … 2 and T H 17
cytokines were also detected. Furthermore, we studied T cell kinetics and showed that SARS-CoV-2…